Page last updated: 2024-11-05

5-nitro-2-furaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

5-Nitro-2-furaldehyde, also known as Nitrofural, is a heterocyclic compound with a nitro group attached to the furan ring. It is a yellow solid and is an important intermediate in the synthesis of various pharmaceuticals and pesticides. It is widely used as a disinfectant, antiseptic, and antimicrobial agent. 5-Nitro-2-furaldehyde is synthesized by nitration of furfural with nitric acid. It exhibits strong antibacterial activity against a broad range of bacteria, particularly Gram-positive bacteria. The mechanism of action involves the inhibition of bacterial enzyme systems, leading to the disruption of cellular processes. However, due to potential toxicity concerns, its use has been limited in some applications. Its effectiveness in inhibiting bacterial growth and its versatility in synthesis make it a valuable compound for research and development in the pharmaceutical and agricultural industries.'

Cross-References

ID SourceID
PubMed CID12774
CHEMBL ID351937
CHEBI ID34459
SCHEMBL ID183545
MeSH IDM0149207

Synonyms (59)

Synonym
STL286539
nsc5574
nsc-5574
5-nitro-5-furancarboxaldehyde
5-furancarboxaldehyde, 5-nitro-
brn 0120539
ccris 1542
nsc 5574
furfural, 5-nitro-
nitrofurfural
nsc 111144
hsdb 4301
ai3-23603
5-nitro-2-furancarboxaldehyde
einecs 211-816-3
5-nitro-2-furaldehyde
5-nitrofurfural
nsc-111144
698-63-5
2-furancarboxaldehyde, 5-nitro-
nsc111144
5-nitrofurfuraldehyde
2-furaldehyde, 5-nitro-
5-nitro-2-furfural
5-nitro-2-furaldehyde, 99%
AC-11279
AKOS000118931
5-nitrofuran-2-carbaldehyde
chebi:34459 ,
CHEMBL351937
N0387
5-nitrofuraldehyde
GEO-02008
xxx18au0z3 ,
5-17-09-00323 (beilstein handbook reference)
unii-xxx18au0z3
c5h3no4
BBL023610
FT-0620689
SCHEMBL183545
5-nitro-2-furaldehyde [hsdb]
furadoxyl
DTXSID30220097
5-nitrofuran-2-aldehyde
5-nitro-furfuraldehyde
5-nitro furaldehyde
5-nitro-furan-2-carbaldehyde
5-nitrofuran-2-carboxaldehyde
5-nitro-furan-2-aldehyde
5-nitro2-furaldehyde
5-nitrofuran aldehyde
W-104581
mfcd00003230
Z56836979
CS-0063793
Q27116084
AS-10914
EN300-35243
SB60918
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
furansCompounds containing at least one furan ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID1766407Electrochemical behavior of the compound in aprotic medium assessed as redox potential using glassy carbon electrode by cyclic voltammetry analysis2021ACS medicinal chemistry letters, Sep-09, Volume: 12, Issue:9
Monocyclic Nitro-heteroaryl Nitrones with Dual Mechanism of Activation: Synthesis and Antileishmanial Activity.
AID1766397Antileishmanial activity against Leishmania amazonensis MHOM/BR/77/LTB 0016 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay2021ACS medicinal chemistry letters, Sep-09, Volume: 12, Issue:9
Monocyclic Nitro-heteroaryl Nitrones with Dual Mechanism of Activation: Synthesis and Antileishmanial Activity.
AID1766405Induction of ROS production in mouse peritoneal macrophages at EC50 concentration measured upto 4 hrs by H2DCFDA probe based fluorescence analysis2021ACS medicinal chemistry letters, Sep-09, Volume: 12, Issue:9
Monocyclic Nitro-heteroaryl Nitrones with Dual Mechanism of Activation: Synthesis and Antileishmanial Activity.
AID1766396Cytotoxicity against BALB/c mouse peritoneal macrophages assessed as reduction in cell viability incubated for 72 hrs by resazurin dye based fluorescence assay2021ACS medicinal chemistry letters, Sep-09, Volume: 12, Issue:9
Monocyclic Nitro-heteroaryl Nitrones with Dual Mechanism of Activation: Synthesis and Antileishmanial Activity.
AID1766398Antileishmanial activity against intracellular Leishmania amazonensis MHOM/BR/77/LTB 0016 amastigotes infected in BALB/c mouse peritoneal macrophage assessed as reduced parasite growth incubated for 72 hrs by PANOTIC staining based assay2021ACS medicinal chemistry letters, Sep-09, Volume: 12, Issue:9
Monocyclic Nitro-heteroaryl Nitrones with Dual Mechanism of Activation: Synthesis and Antileishmanial Activity.
AID200690Mutagenic activity in an Ames test on Salmonella Typhimurium TA98; Activity is log of revertants/nmol1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID1766416Selectivity index, ratio of CC50 for cytotoxicity against BALB/c mouse peritoneal macrophages assessed as reduction in cell viability incubated for 72 hrs by resazurin dye based fluorescence assay to IC50 for antileishmanial activity against intracellular2021ACS medicinal chemistry letters, Sep-09, Volume: 12, Issue:9
Monocyclic Nitro-heteroaryl Nitrones with Dual Mechanism of Activation: Synthesis and Antileishmanial Activity.
AID1766400Antileishmanial activity against intracellular Leishmania infantum MHOM/MA/67/ITMAP-263 amastigotes infected in BALB/c mouse peritoneal macrophage assessed as reduced parasite growth incubated for 72 hrs by PANOTIC staining based assay2021ACS medicinal chemistry letters, Sep-09, Volume: 12, Issue:9
Monocyclic Nitro-heteroaryl Nitrones with Dual Mechanism of Activation: Synthesis and Antileishmanial Activity.
AID23442Partition coefficient (logP)1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID1766406Induction of ROS production in Leishmania amazonensis promastigotes measured by H2DCFDA probe based fluorescence analysis2021ACS medicinal chemistry letters, Sep-09, Volume: 12, Issue:9
Monocyclic Nitro-heteroaryl Nitrones with Dual Mechanism of Activation: Synthesis and Antileishmanial Activity.
AID1766399Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay2021ACS medicinal chemistry letters, Sep-09, Volume: 12, Issue:9
Monocyclic Nitro-heteroaryl Nitrones with Dual Mechanism of Activation: Synthesis and Antileishmanial Activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (40)

TimeframeStudies, This Drug (%)All Drugs %
pre-199029 (72.50)18.7374
1990's2 (5.00)18.2507
2000's1 (2.50)29.6817
2010's6 (15.00)24.3611
2020's2 (5.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.48 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index5.14 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (97.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]